Cidara Therapeutics Inc (CDTX)
20.68
+3.23
(+18.51%)
USD |
NASDAQ |
Nov 22, 16:00
21.31
+0.63
(+3.05%)
After-Hours: 20:00
Cidara Therapeutics Total Assets (Quarterly): 162.33M for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 162.33M |
| June 30, 2024 | 173.36M |
| March 31, 2024 | 52.72M |
| December 31, 2023 | 67.03M |
| September 30, 2023 | 63.47M |
| June 30, 2023 | 67.99M |
| March 31, 2023 | 81.74M |
| December 31, 2022 | 47.49M |
| September 30, 2022 | 66.86M |
| June 30, 2022 | 39.52M |
| March 31, 2022 | 55.30M |
| December 31, 2021 | 75.32M |
| September 30, 2021 | 51.21M |
| June 30, 2021 | 63.74M |
| March 31, 2021 | 54.21M |
| December 31, 2020 | 60.42M |
| September 30, 2020 | 63.67M |
| June 30, 2020 | 73.40M |
| March 31, 2020 | 84.10M |
| December 31, 2019 | 68.98M |
| Date | Value |
|---|---|
| September 30, 2019 | 81.70M |
| June 30, 2019 | 51.75M |
| March 31, 2019 | 64.31M |
| December 31, 2018 | 79.11M |
| September 30, 2018 | 92.81M |
| June 30, 2018 | 107.01M |
| March 31, 2018 | 70.25M |
| December 31, 2017 | 79.04M |
| September 30, 2017 | 67.44M |
| June 30, 2017 | 81.16M |
| March 31, 2017 | 92.76M |
| December 31, 2016 | 106.96M |
| September 30, 2016 | 82.23M |
| June 30, 2016 | 90.02M |
| March 31, 2016 | 99.22M |
| December 31, 2015 | 109.97M |
| September 30, 2015 | 116.99M |
| June 30, 2015 | 123.95M |
| March 31, 2015 | 60.78M |
| December 31, 2014 | 24.35M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
39.52M
Minimum
Jun 2022
173.36M
Maximum
Jun 2024
73.64M
Average
65.30M
Median
Total Assets (Quarterly) Benchmarks
| Biomarin Pharmaceutical Inc | 6.851B |
| Arbutus Biopharma Corp | 140.44M |
| GlycoMimetics Inc | 15.70M |
| FibroGen Inc | 264.42M |
| Cue Biopharma Inc | 44.81M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 46.70M |
| Shareholders Equity (Quarterly) | 115.63M |